It is postulated that due to the orthologous relationship between LILRB2 and PirB, LILRB2 may contribute to Alzheimer’s disease neuropathology, and might be a suitable therapeutic target. The gene discussed is LILRB3; the disease is early-onset autosomal dominant Alzheimer disease.